skip to primary navigationskip to content
 

Publication highlights 2011

  1. Microbial sequences benefit health now.  Cartwright EJ, Köser CU, Peacock SJ. Nature. 2011 Mar 31;471(7340):578 
  2. Meticillin-resistant Staphylococcus aureus with a novel mecA homologue in human and bovine populations in the UK and Denmark: a descriptive study. García-Álvarez L, Holden MT, Lindsay H, Webb CR, Brown DF, Curran MD, Walpole E, Brooks K, Pickard DJ, Teale C, Parkhill J, Bentley SD, Edwards GF, Girvan EK, Kearns AM, Pichon B, Hill RL, Larsen AR, Skov RL, Peacock SJ, Maskell DJ, Holmes MA. Lancet Infect Dis. 2011 Jun 2. [Epub ahead of print]
  3. Genomics. The genomic view of bacterial diversification. Enright MC, Spratt BG. Science. 2011 Jan 28;331(6016):407-9.
  4. Rapid pneumococcal evolution in response to clinical interventions. Croucher NJ, Harris SR, Fraser C, Quail MA, Burton J, van der Linden M, McGee L, von Gottberg A, Song JH, Ko KS, Pichon B, Baker S, Parry CM, Lambertsen LM, Shahinas D, Pillai DR, Mitchell TJ, Dougan G, Tomasz A, Klugman KP, Parkhill J, Hanage WP, Bentley SD. Science. 2011 Jan 28;331(6016):430-4.
  5. Clinical impact of antimicrobial resistance: design matters. Grundmann H, de Kraker M, Davey P. Lancet Infect Dis. 2011 May;11(5):344.
  6. A framework for global surveillance of antibiotic resistance. Grundmann H, Klugman KP, Walsh T, Ramon-Pardo P, Sigauque B, Khan W, Laxminarayan R, Heddini A, Stelling J. Drug Resist Updat. 2011 Apr;14(2):79-87. Epub 2011 Apr 8.
  7. Burden of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay associated with bloodstream infections due to Escherichia coli resistant to third-generation cephalosporins. de Kraker ME, Wolkewitz M, Davey PG, Koller W, Berger J, Nagler J, Icket C, Kalenic S, Horvatic J, Seifert H, Kaasch A, Paniara O, Argyropoulou A, Bompola M, Smyth E, Skally M, Raglio A, Dumpis U, Melbarde Kelmere A, Borg M, Xuereb D, Ghita MC, Noble M, Kolman J, Grabljevec S, Turner D, Lansbury L, Grundmann H. J Antimicrob Chemother. 2011 Feb;66(2):398-407. Epub 2010 Nov 23.
  8. No effect of 2008/09 seasonal influenza vaccination on the risk of pandemic H1N1 2009 influenza infection in England. Pebody R, Andrews N, Waight P, Malkani R, McCartney C, Ellis J, Miller E. Vaccine. 2011 Mar 21;29(14):2613-8. Epub 2011 Feb 1.
  9. Oligosaccharide conjugates of Bordetella pertussis and bronchiseptica induce bactericidal antibodies, an addition to pertussis vaccine. Kubler-Kielb J, Vinogradov E, Lagergård T, Ginzberg A, King JD, Preston A, Maskell DJ, Pozsgay V, Keith JM, Robbins JB, Schneerson R. Proc Natl Acad Sci U S A. 2011 Mar 8;108(10):4087-92. Epub 2011 Feb 22.
  10. Population biology of Gram-positive pathogens: high-risk clones for dissemination of antibiotic resistance. Willems RJ, Hanage WP, Bessen DE, Feil EJ. FEMS Microbiol Rev. 2011 Jun 9. doi: 10.1111/j.1574-6976.2011.00284.x. [Epub ahead of print]

Navy Blue Logo CID PNG

A virtual centre for infectious diseases researchers at the University of Cambridge and affiliated institutes. Our vision is to build a world-leading interdisciplinary centre with capacity to develop innovative solutions for intractable infectious disease problems and support evidence for infectious disease policy.